Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Local complement activation is associated with primary graft dysfunction after lung transplantation

Research output: Contribution to journalJournal articlepeer-review

  1. RAGE has potential pathogenetic and prognostic value in non-intubated hospitalized patients with COVID-19

    Research output: Contribution to journalJournal articlepeer-review

  2. Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R-dependent manner

    Research output: Contribution to journalJournal articlepeer-review

  3. Asymmetric cell division promotes therapeutic resistance in glioblastoma stem cells

    Research output: Contribution to journalJournal articlepeer-review

  • Hrishikesh S Kulkarni
  • Kristy Ramphal
  • Lina Ma
  • Melanie Brown
  • Michelle Oyster
  • Kaitlyn N Speckhart
  • Tsuyoshi Takahashi
  • Derek E Byers
  • Mary K Porteous
  • Laurel Kalman
  • Ramsey R Hachem
  • Melanie Rushefski
  • Ja'Nia McPhatter
  • Marlene Cano
  • Daniel Kreisel
  • Masina Scavuzzo
  • Brigitte Mittler
  • Edward Cantu
  • Katrine Pilely
  • Peter Garred
  • Jason D Christie
  • John P Atkinson
  • Andrew E Gelman
  • Joshua M Diamond
View graph of relations

BACKGROUNDThe complement system plays a key role in host defense but is activated by ischemia/reperfusion injury (IRI). Primary graft dysfunction (PGD) is a form of acute lung injury occurring predominantly due to IRI, which worsens survival after lung transplantation (LTx). Local complement activation is associated with acute lung injury, but whether it is more reflective of allograft injury compared with systemic activation remains unclear. We proposed that local complement activation would help identify those who develop PGD after LTx. We also aimed to identify which complement activation pathways are associated with PGD.METHODSWe performed a multicenter cohort study at the University of Pennsylvania and Washington University School of Medicine. Bronchoalveolar lavage (BAL) and plasma specimens were obtained from recipients within 24 hours after LTx. PGD was scored based on the consensus definition. Complement activation products and components of each arm of the complement cascade were measured using ELISA.RESULTSIn both cohorts, sC4d and sC5b-9 levels were increased in BAL of subjects with PGD compared with those without PGD. Subjects with PGD also had higher C1q, C2, C4, and C4b, compared with subjects without PGD, suggesting classical and lectin pathway involvement. Ba levels were higher in subjects with PGD, suggesting alternative pathway activation. Among lectin pathway-specific components, MBL and FCN-3 had a moderate-to-strong correlation with the terminal complement complex in the BAL but not in the plasma.CONCLUSIONComplement activation fragments are detected in the BAL within 24 hours after LTx. Components of all 3 pathways are locally increased in subjects with PGD. Our findings create a precedent for investigating complement-targeted therapeutics to mitigate PGD.FUNDINGThis research was supported by the NIH, American Lung Association, Children's Discovery Institute, Robert Wood Johnson Foundation, Cystic Fibrosis Foundation, Barnes-Jewish Hospital Foundation, Danish Heart Foundation, Danish Research Foundation of Independent Research, Svend Andersen Research Foundation, and Novo Nordisk Research Foundation.

Original languageEnglish
Article numbere138358
JournalJCI Insight
Volume5
Issue number17
Pages (from-to)e138358
ISSN2379-3708
DOIs
Publication statusPublished - 3 Sep 2020

ID: 61698304